Geron
GERN
#6742
Rank
C$1.12 B
Marketcap
C$1.75
Share price
0.41%
Change (1 day)
-10.28%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -C$51.83 Million

According to Geron's latest financial reports the company's current earnings are C$0.20 Billion. In 2025 the company made an earning of -C$72.48 Million, an increase over its 2024 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$51.83 Million-28.49%
2025 -C$72.48 Million-67.42%
2024 -C$0.23 Billion-11.23%
2023 -C$0.26 Billion30.22%
2022 -C$0.2 Billion20.15%
2021 -C$0.17 Billion50.08%
2020 -C$0.11 Billion4.46%
2019 -C$0.11 Billion130.68%
2018 -C$44.3 Million8.84%
2017 -C$40.7 Million-3.08%
2016 -C$41.99 Million-22080.6%
2015 C$0.19 M-100.38%
2014 -C$50.73 Million-7.14%
2013 -C$54.63 Million
2011 -C$0.13 Billion19.04%
2010 -C$0.11 Billion8.45%
2009 -C$0.11 Billion-2.51%
2008 -C$0.11 Billion14.65%
2007 -C$89.58 Million32.68%
2006 -C$67.51 Million25.59%
2005 -C$53.76 Million4.36%
2004 -C$51.51 Million19.73%
2003 -C$43.02 Million-15.46%
2002 -C$50.89 Million1.94%
2001 -C$49.92 Million33.59%
2000 -C$37.37 Million27.53%
1999 -C$29.3 Million63.13%
1998 -C$17.97 Million15.6%
1997 -C$15.54 Million-10.66%
1996 -C$17.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-C$2.79 Billion 5,130.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$2.80 B-5,363.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$98.7 Million 85.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.35 B-769.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$23.55 Million-55.80%๐Ÿ‡บ๐Ÿ‡ธ USA